France
- develop the strategic plan for epidemiology evidence generation and valuation for a range of existing and pipeline vaccines with input from internal and external experts; advocate for funding and resources prioritization, and implement the strategy in collaboration with local affiliates and independent investigators - lead a multifunctional team in charge of the scientific and logistical aspects of corporate involvement in investigator sponsored studies, including study design, financial, logistical and equipment support, data analysis, interpretation and communication - deliver epidemiology advice and input in commercial/medical communication strategies and in the design and use of informed decision frameworks for new vaccine development strategies - develop and maintain open and transparent interactions with key opinion leaders focusing on strategic scientific topics and evidence-based evaluation of healthcare interventions
Dr. Vidal, BMI Dpt. Lee SH, Girard S, Macina D, Busa M, Zafer A, Belouchi A, Gros P, Vidal SM. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nature Genetics 2001; 28:42-45